SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169232-05-000502
Filing Date
2005-02-07
Accepted
2005-02-07 16:26:01
Documents
4
Period of Report
2005-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT d62096_8k.htm 8-K 20428
2 EMPLOYMENT AGREEMENT d62096_ex10-1.htm EX-10.1 25278
3 PRESS RELEASE d62096_ex99-1.htm EX-99.1 17398
4 GRAPHIC img1.gif GRAPHIC 2873
  Complete submission text file 0001169232-05-000502.txt   68082
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 05580794
SIC: 2836 Biological Products, (No Diagnostic Substances)